Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-18

FDA Approved: STRENSIQ — Supplemental Application (Alexion Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approves a supplemental application for STRENSIQ (asfotase alfa) from Alexion Pharmaceuticals. This action updates the approved labeling/indication for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • STRENSIQ (asfotase alfa)

Snippet

SUPPL AP for STRENSIQ (ASFOTASE ALFA)